United States Antimony reports Q2 revenue of $7.9M, missing estimates by $13.77M and cutting its 2026 outlook.
United States Antimony (UAMY) shares plunged 14% in premarket trading after reporting a 24.7% year-over-year decline in Q2 revenue to $7.9M. The result fell short of expectations by $13.77M, driven by a sharp drop in antimony sales.
The company also lowered its full-year 2026 revenue outlook, citing weaker demand and pricing pressures. Prior estimates had projected stronger performance, but market conditions have deteriorated since the last quarter.
Premarket trading reflected investor disappointment, with UAMY shares extending losses following the announcement.